NeoChord (Series C)

Funding Details
Awarder
Inbox
Date Award
June 09, 2015
Vertical
Medical Technology
Funding URL
View Funding Page
Funding Amount:
$20,000,000
Company Info
Company Description
NeoChord is a privately held medical technology company focused on advancing the treatment of mitral regurgitation. The Company received CE marking in December 2012 for the DS1000 device for minimally invasive mitral valve repair via surgical implantation of artificial chordae tendinae.
Market
Mitral Regurgitation Treatment
Location
Eden Prairie, Minnesota, USA
Coinvestors
Baird Capital, Deerfield Management Company, L.P., Heron Capital, TGAP Ventures
Links
Back to Home Back to Medical Technology Deals View Funding Announcement